Bed Rest Intervention for Type 2 Diabetes

AdventHealth Translational Research Institute, Orlando, FL
Type 2 Diabetes+4 More ConditionsBed Rest Intervention - Behavioral
Eligibility
60 - 80
All Sexes

Study Summary

This trial is testing how well exercise can help people with pre-diabetes and type 2 diabetes recover from bedrest.

Eligible Conditions
  • Type 2 Diabetes
  • Muscular Atrophy
  • Sedentary Lifestyle
  • Prediabetes
  • Exercise

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: Immediately following bed rest, and following the exercise or non-exercise recovery phase

Immediately following bed rest, and following the exercise or non-exercise recovery phase
Leg Lean Mass
mmediately following bed rest, and following the exercise or non-exercise recovery phase
Insulin Sensitivity
Mitochondrial Respiration
Physical function

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Exercise Recovery
1 of 2
Non-Exercise Recovery
1 of 2

Experimental Treatment

12 Total Participants · 2 Treatment Groups

Primary Treatment: Bed Rest Intervention · No Placebo Group · N/A

Exercise RecoveryExperimental Group · 2 Interventions: Bed Rest Intervention, Exercise Program · Intervention Types: Behavioral, Behavioral
Non-Exercise Recovery
Behavioral
Experimental Group · 1 Intervention: Bed Rest Intervention · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise Program
2016
Completed Phase 3
~4950

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: immediately following bed rest, and following the exercise or non-exercise recovery phase

Who is running the clinical trial?

Translational Research Institute for Metabolism and Diabetes, FloridaLead Sponsor
40 Previous Clinical Trials
3,526 Total Patients Enrolled
AdventHealth Translational Research InstituteLead Sponsor
45 Previous Clinical Trials
20,037 Total Patients Enrolled
Paul Coen, PhDPrincipal InvestigatorPrincipal Investigator
5 Previous Clinical Trials
219 Total Patients Enrolled

Eligibility Criteria

Age 60 - 80 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
New York100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%

Frequently Asked Questions

What is the current count of participants in this medical experiment?

"Affirmative. The clinicaltrials.gov website states that this medical experiment, which was published on December 20th 2019, is actively searching for participants. Approximately 50 individuals are needed from one research centre." - Anonymous Online Contributor

Unverified Answer

For whom is this experiment the most suitable?

"This medical trial is enrolling 50 individuals aged between 60 and 80 who have been diagnosed with type 2 diabetes. Participants must agree to the protocol, be either male or female, present an HbA1C level of less than 8%, not use insulin injections nor certain other medications, possess renal function of more than 45 ml/min/1.73m2 with triglyceride levels below 350 mg/dl and LDL cholesterol no higher than 150mg/dl as well as sign a consent form approved by their Institutional Review Board and provide HIPAA authorization before being accepted for the study." - Anonymous Online Contributor

Unverified Answer

Is there still room for participants in this experiment?

"Affirmative, current information on clinicaltrials.gov suggests that this research trial is still accepting participants. It was originally posted in December of 2019 and last modified in May of 2022; the study aims to recruit 50 subjects from a single site." - Anonymous Online Contributor

Unverified Answer

Does this research endeavor accept participants over the age of 60?

"As per the specifications of this medical trial, patients must be above 60 years old and below 80 in order to participate." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.